Prism Medico and Pharmacy Share Price

24.800.30 (1.22%)

BSE

Live
As On:
As On: 30 Aug, 2024, 01:31 PM IST

Sector: Trading
Industry: Trading

STOCK SCORE

Unlock Scores

Add to Watchlist

OpenN.A.
HighN.A.
LowN.A.
Prev CloseN.A.
VolumeN.A.
VWAP(₹)N.A.

Prism Medico share price insights

Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 139.53% outperformed its 3 year CAGR of -43.03%. (Source: Standalone Financials)
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 393.95% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 1.16% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Prism Medico Share Price Update
Prism Medico and Pharmacy Ltd. share price moved up by 1.22% from its previous close of Rs 24.50. Prism Medico and Pharmacy Ltd. stock last traded price is 24.80
Share Price Value
Today/Current/Last -24.80
Previous Day -24.50

Share Price	Value
Today/Current/Last	-24.80
Previous Day	-24.50

Prism Medico Share Price Returns

1 Day	1.22%
1 Month	-10.28%
3 Months	16.0%
1 Year	-2.13%
3 Years	380.62%
5 Years	-3.69%

Key Metrics

PE Ratio(x)	-677.36
EPS - TTM(₹)	-0.04
MCap(₹ Cr.)	15.01
MCap Rank	74
PB Ratio(x)	0.98
Div Yield(%)	0.00
Face Value(₹)	10.00
52W High(₹)	39.20
52W Low(₹)	19.06
MCap/Sales	5.66
Beta(1 Month)	-0.18
BV/Share(₹)	24.97

Prism Medico Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Prism Medico News & Analysis

View all Prism Medico Share News & Announcements

Prism Medico Financials

Consolidated

Income (P&L)

	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018
Total Income	9.78	6.62	8.71	16.75	17.13
Total Income Growth (%)	47.61	-23.96	-48.01	-2.22	13.76
Total Expenses	9.75	6.47	8.63	17.55	16.96
Total Expenses Growth (%)	50.67	-25.01	-50.83	3.51	14.93
EBIT	0.03	0.15	0.08	-0.80	0.18
EBIT Growth (%)	-82.84	89.38	-	-555.69	-42.71
Profit after Tax (PAT)	-0.04	0.09	0.13	-0.70	0.15
PAT Growth (%)	-147.33	-27.85	-	-578.31	-46.97
EBIT Margin (%)	0.27	2.29	0.92	-4.78	1.02
Net Profit Margin (%)	-0.45	1.42	1.49	-4.20	0.86
Basic EPS (₹)	-0.07	0.15	0.21	0.00	0.24

	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Total Income	0.06	0.24	2.75	0.04	0.02
Total Income Growth (%)	-73.02	-91.26	0.00	165.64	-98.72
Total Expenses	0.15	0.31	2.55	0.10	0.10
Total Expenses Growth (%)	-51.05	-87.70	2,516.70	-4.69	-91.78
EBIT	-0.09	-0.07	0.19	-0.05	-0.09
EBIT Growth (%)	-	-138.20	-	-	-432.43
Profit after Tax (PAT)	-0.09	-0.07	0.19	-0.05	-0.09
PAT Growth (%)	-	-135.64	-	-	-275.54
EBIT Margin (%)	-137.35	-30.81	7.05	-125.40	-528.22
Net Profit Margin (%)	-138.89	-28.14	6.90	-125.40	-546.01
Basic EPS (₹)	-0.15	-0.11	0.31	-0.09	-0.15

	FY 2019	FY 2018
Total Revenue	54.72	22.84
Total Revenue Growth (%)	139.55	327.17
Total Expenses	54.82	22.78
Total Expenses Growth (%)	140.69	309.62
Profit after Tax (PAT)	0.04	0.00
PAT Growth (%)	-	-
Operating Profit Margin (%)	0.01	1.56
Net Profit Margin (%)	0.07	-0.01
Basic EPS (₹)	0.07	-0.01

	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	3.05	1.27	8.44	16.76	26.89
Total Revenue Growth (%)	139.53	-84.93	-49.63	-37.66	-26.38
Total Expenses	3.08	1.37	8.94	16.94	26.96
Total Expenses Growth (%)	123.73	-84.63	-47.20	-37.17	-25.59
Profit after Tax (PAT)	-0.02	-0.08	-0.37	-0.13	-0.05
PAT Growth (%)	-	-	-	-	-113.60
Operating Profit Margin (%)	-0.71	-8.02	-5.90	-1.04	-0.25
Net Profit Margin (%)	-0.72	-6.01	-4.38	-0.77	-0.18
Basic EPS (₹)	-0.04	-0.13	-0.61	-0.21	-0.08

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 139.53% outperformed its 3 year CAGR of -43.03%. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 1.16% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

Balance Sheet

Annual	FY 2019	FY 2018
Total Assets	21.20	15.80
Total Assets Growth (%)	34.21	-8.48
Total Liabilities	8.29	2.93
Total Liabilities Growth (%)	183.23	-33.26
Total Equity	12.91	12.87
Total Equity Growth (%)	0.31	-0.03
Current Ratio (x)	1.31	1.35
Total Debt to Equity (x)	0.18	0.17
Contingent Liabilities	-	4.54

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	15.24	15.39	12.57	21.54	21.58
Total Assets Growth (%)	-0.97	22.43	-41.64	-0.19	27.17
Total Liabilities	0.10	0.23	0.02	8.62	8.53
Total Liabilities Growth (%)	-56.52	1,050.00	-99.77	1.06	123.30
Total Equity	15.14	15.16	12.55	12.93	13.06
Total Equity Growth (%)	-0.13	20.80	-2.94	-1.00	-0.68
Current Ratio (x)	212.01	65.34	708.22	2.26	2.29
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	0.00	-	-	-	-

All figures in Rs Cr, unless mentioned otherwise

Insights

Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)

Cash Flows

Annual	FY 2019	FY 2018
Net Cash flow from Operating Activities	-0.44	3.55
Net Cash used in Investing Activities	-	-2.53
Net Cash flow from Financing Activities	-0.50	-1.61
Net Cash Flow	-0.94	-0.59
Closing Cash & Cash Equivalent	0.41	1.36
Closing Cash & Cash Equivalent Growth (%)	-69.58	-
Total Debt/ CFO (x)	-5.16	0.61

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	-0.01	2.95	-2.38	-0.05	-4.36
Net Cash used in Investing Activities	-	-2.91	2.35	0.02	4.36
Net Cash flow from Financing Activities	-0.01	-3,254.00	-4,602.40	-2,466.00	-2,494.00
Net Cash Flow	-0.01	0.04	-0.03	-0.03	-0.01
Closing Cash & Cash Equivalent	0.08	0.10	0.06	0.08	0.11
Closing Cash & Cash Equivalent Growth (%)	-12.68	73.74	-34.51	-24.72	-4.96
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

Ratios

Annual	FY 2019	FY 2018
Return on Equity (%)	0.31	-0.03
Return on Capital Employed (%)	0.08	2.74
Return on Assets (%)	0.18	-0.02
Interest Coverage Ratio (x)	3.67	2.78
Asset Turnover Ratio (x)	2.94	1.38
Price to Earnings (x)	588.24	-5,000.00
Price to Book (x)	1.74	1.12
EV/EBITDA (x)	61.76	19.02
EBITDA Margin (%)	0.72	3.52

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	-0.14	-0.50	-2.94	-1.00	-0.38
Return on Capital Employed (%)	-0.13	-0.67	-3.97	-1.35	-0.51
Return on Assets (%)	-0.13	-0.49	-2.94	-0.60	-0.23
Interest Coverage Ratio (x)	-2.20	-293.14	-1,064.32	-709.78	-272.12
Asset Turnover Ratio (x)	0.19	0.09	0.50	77.81	124.58
Price to Earnings (x)	-833.33	-227.27	-12.50	-54.64	-153.85
Price to Book (x)	1.09	1.15	0.37	0.55	0.58
EV/EBITDA (x)	-1,054.96	-180.98	-9.32	-42.94	-148.01
EBITDA Margin (%)	-0.53	-7.50	-5.80	-0.96	-0.18

Insights

Losing Shareholder's Money
Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Prism Medico	-677.36	0.99	-0.14	-0.13	-0.13	-43.03	-0.71	-0.72	-0.04	212.01	0.00	0.00
Mayukh Dealtrade	13.84	0.90	5.26	6.84	5.11	39.60	43.51	33.50	0.48	16.38	0.01	-0.07
Regent Enterprises	13.42	0.51	1.67	0.54	0.96	6.45	0.03	0.09	0.19	2.42	0.00	0.00
Globe Commercials	2.95	1.51	24.43	29.94	5.23	912.41	2.57	1.88	5.09	1.14	0.12	0.12
Shree Ganesh	7.91	3.23	29.56	32.45	20.75	23.45	8.52	6.91	2.96	4.32	0.15	0.27

Annual Ratios (%)

Stock Performance

TABLE

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Prism Medico Stock Performance	1.22	2.99	-11.40	14.23	-2.09	400.00	3.55
Mayukh Dealtrade Stock Performance	4.20	7.39	34.24	0.00	-31.85	-77.93	37.97
Regent Enterprises Stock Performance	-2.96	-2.96	7.47	46.77	76.12	201.02	0.00
Globe Commercials Stock Performance	4.68	17.58	26.00	0.00	5.00	0.00	0.00
Shree Ganesh Stock Performance	-1.99	-11.30	-0.70	15.96	0.00	52.81	0.00

All values in %

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 393.95% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Board Meeting
Quarterly Results
Aug 07, 2024
Board Meeting
Audited Results
May 22, 2024
Board Meeting
Quarterly Results
Feb 05, 2024

Board Meetings

Announced on	Meeting on
Aug 07, 2024	Aug 14, 2024
Quarterly Results
May 22, 2024	May 29, 2024
Audited Results
Feb 05, 2024	Feb 13, 2024
Quarterly Results
Nov 01, 2023	Nov 08, 2023
Quarterly Results
Aug 07, 2023	Aug 14, 2023
Quarterly Results

Dividends
No Data Available
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available

AGM/EGM Meetings

Announced on	Meeting on
Sep 14, 2023	Sep 30, 2023
A.G.M.
Jul 20, 2023	Aug 14, 2023
-
Sep 05, 2022	Sep 30, 2022
-
Aug 13, 2020	Sep 10, 2020
Book closure from Sep 4, 2020 to Sep 10, 2020
Aug 30, 2019	-
Book closure from Sep 24, 2019 to Sep 30, 2019

About

Prism Medico and Pharmacy Ltd., incorporated in the year 2002, is a Small Cap company (having a market cap of Rs 14.86 Crore) operating in Trading sector.

Prism Medico and Pharmacy Ltd. key Products/Revenue Segments include Agriculture Products for the year ending 31-Mar-2023.

For the quarter ended 30-06-2024, the company has reported a Standalone Total Income of Rs .06 Crore, down 73.02 % from last quarter Total Income of Rs .24 Crore and up 297.55 % from last year same quarter Total Income of Rs .02 Crore. Company has reported net profit after tax of Rs -.09 Crore in latest quarter.

The company’s top management includes Ms.Sakshi Laller, Mrs.Dinesh Kumar, Mr.Pardeep Kumar, Mr.Davender Singh, Mr.Vishwambhar Dayal Gupta, Mr.Bharat Singh, Mr.Sameer Gupta. Company has Harjeet Parvesh & Company as its auditors. As on 30-06-2024, the company has a total of .61 Crore shares outstanding.

About Prism Medico

Prism Medico and Pharmacy Ltd., incorporated in the year 2002, is a Small Cap company (having a market cap of Rs 14.86 Crore) operating in Trading sector. Prism Medico and Pharmacy Ltd. key Products/Revenue Segments include Agriculture Products for the year ending 31-Mar-2023.For the quarter ended 30-06-2024, the company has reported a Standalone Total Income of Rs .06 Crore, down 73.02 % from last quarter Total Income of Rs .24 Crore and up 297.55 % from last year same quarter Total Income of Rs .02 Crore. Company has reported net profit after tax of Rs -.09 Crore in latest quarter.The company’s top management includes Ms.Sakshi Laller, Mrs.Dinesh Kumar, Mr.Pardeep Kumar, Mr.Davender Singh, Mr.Vishwambhar Dayal Gupta, Mr.Bharat Singh, Mr.Sameer Gupta. Company has Harjeet Parvesh & Company as its auditors. As on 30-06-2024, the company has a total of .61 Crore shares outstanding.

Industry

Trading

Key Indices Listed On

Address

Suketi Road,Kala Amb,Sirmour, Himachal Pradesh - 173030

Contact

investorgrievancewmcl@gmail.com

http://www.prismmedico.in

Executive Leadership

Sakshi Laller

Whole Time Director

Dinesh Kumar

Independent Director

Pardeep Kumar

Independent Director

Davender Singh

Director

Auditors

Harjeet Parvesh & Company

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

Prism Medico and Pharmacy Share Price

Prism Medico share price insights

Prism Medico Share Price Returns

Key Metrics

Prism Medico Share Recommendations

Prism Medico News & Analysis

Prism Medico Financials

Income (P&L)

Balance Sheet

Cash Flows

Ratios

Peer Comparison

Ratio Performance

Stock Performance

Mutual Funds Ownership

Corporate Actions

Recent

Board Meetings

Dividends

Bonus

Splits

Rights

AGM/EGM Meetings

About

About Prism Medico

Executive Leadership

Auditors

Equity Quick Links

More from Markets

Trending in Markets

Most Recent

Most Read

Browse Companies

Trending Now

Popular Categories

Hot on Web

In Case you missed it

More from our network

Latest News

Download ET APP

Follow us on

become a member